Keyword News: [stem cell]

Yahoo! Alerts

Yahoo! News - My Alerts - Edit Alert

Friday, March 14, 2008 11:31 PM PDT

Embryo research Bill could block life-saving stem-cell treatments Times Online Fri, 14 Mar 2008 4:04 PM PDT Stem-cell therapies for diseases such as Parkinson's and diabetes could become illegal under embryo research laws planned by the Government, The Times has learnt. VistaGen Therapeutics Announces Broad Stem Cell R&D Alliance With Toronto's University Health Network And The McEwen ... BioresearchOnline Fri, 14 Mar 2008 6:30 AM PDT VistaGen Therapeutics, Inc., a biotechnology company using embryonic stem (ES) cell technologies to discover and develop new drugs for diabetes and neurological disorders, announced an expansive ES cell research alliance with Toronto's University Health Network (UHN), Canada's leading research hospital, and its stem cell research affiliate, the McEwen Centre for Regenerative Medicine U.S. Patent Office Upholds Patents On Human Embryonic Stem Cell Technology Medical News Today Fri, 14 Mar 2008 6:07 AM PDT The U.S. Patent and Trademark Office in a ruling made public Tuesday upheld two patents on human embryonic stem cell technology held by the Wisconsin Alumni Research Foundation, the AP/Google.com reports. It's all about the stem cells, baby: patents upheld, Madison to host World Stem Cell Summit Isthmus Fri, 14 Mar 2008 10:01 PM PDT A city committee deadlocks on a vote to choose between two proposals to redevelop the old Garver Feed Mill on the east side. Stem Cell drive for Matt Johnson San Juan Journal Fri, 14 Mar 2008 3:02 PM PDT Matt and Jackie Johnson with their children, Dustin 7, Tesa 4, and twin girls Taylor & Jordyn 15 months. Consensus is close on cuts to O'Malley's budget Baltimore Sun Fri, 14 Mar 2008 4:56 PM PDT Stem cell research is sticking point for House, Senate leaders Senate and House of Delegates leaders are nearing consensus on deep cuts to Gov. Martin O'Malley's budget, including major reductions for Chesapeake Bay cleanup, health care, transportation and economic development. Publication Of Clinical Results Underscores VELCADE(R) (Bortezomib) For Injection Based Therapy As A Standard Of Care ... Medical News Today Fri, 14 Mar 2008 1:09 AM PDT Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) announced the publication of updated results of the Phase I/II clinical trial of the combination therapy VELCADE, melphalan and prednisone (VcMP) in newly diagnosed multiple myeloma patients, who were ineligible for stem cell transplantation.

See more news stories that match my keyword

You received this email because you subscribed to Yahoo! Alerts. Use this link to unsubscribe from this alert. To change your communications preferences for other Yahoo! business lines, please visit your Marketing Preferences. To learn more about Yahoo!'s use of personal information, including the use of web beacons in HTML-based email, please read our Privacy Policy. Yahoo! is located at 701 First Avenue, Sunnyvale, CA 94089.